[HTML][HTML] Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A …
…, M Sathekge, L Kabasakal, FO Garcia-Perez… - European Journal of …, 2021 - Springer
Introduction The impact of prior therapies, especially chemotherapy, on overall survival (OS)
in patients with castration-resistant prostate cancer (CRPC) receiving [ 177 Lu]Lu-PSMA-…
in patients with castration-resistant prostate cancer (CRPC) receiving [ 177 Lu]Lu-PSMA-…
Clinical translation of a PSMA inhibitor for 99mTc-based SPECT
…, J Davanzo, FO García-Pérez - Nuclear medicine and …, 2017 - Elsevier
Background Prostate-specific membrane antigen (PSMA) is highly over-expressed in advanced
prostate cancers. Ga-labeled PSMA inhibitors (iPSMA) are currently used for prostate …
prostate cancers. Ga-labeled PSMA inhibitors (iPSMA) are currently used for prostate …
99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients
…, J Davanzo, G Ferro-Flores, FO García-Pérez… - Nuclear Medicine and …, 2017 - Elsevier
The prostate-specific membrane antigen (PSMA) is expressed in epithelial cells of the prostate
and highly overexpressed in 95% of advanced prostate cancers. The aims of this study …
and highly overexpressed in 95% of advanced prostate cancers. The aims of this study …
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study
…, L Kabasakal, A Yordanova, FO Garcia-Perez… - European Journal of …, 2021 - Springer
Introduction Prostate-specific membrane antigen (PSMA)-based radioligand therapy (RLT)
showed in a multicentre WARMTH (World Association of Radiopharmaceutical and Molecular …
showed in a multicentre WARMTH (World Association of Radiopharmaceutical and Molecular …
Imaging of bacteria with radiolabeled ubiquicidin by SPECT and PET techniques
…, MA Avila-Rodríguez, FO García-Pérez - Clinical and …, 2016 - Springer
The ability to differentiate infection from sterile inflammation and monitor antimicrobial
therapy against multidrug-resistant pathogens through imaging of bacteria with radiolabeled …
therapy against multidrug-resistant pathogens through imaging of bacteria with radiolabeled …
Diagnosis and treatment of drug-resistant tuberculosis
…, JA Cayla, JM Garcia-Garcia, FJ Garcia-Perez… - Archivos de …, 2017 - Elsevier
In the last 2 decades, drug-resistant tuberculosis has become a threat and a challenge to
worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much …
worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much …
[HTML][HTML] Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic …
Q Pitalua-Cortes, FO Garcia-Perez… - Frontiers in …, 2021 - frontiersin.org
Introduction Thyroid cancer is the main endocrine neoplasia worldwide, for which 131 I
therapy is the cornerstone treatment. One of the main problems of follow up in patients with this …
therapy is the cornerstone treatment. One of the main problems of follow up in patients with this …
[HTML][HTML] Head to head comparison performance of 99mTc-EDDA/HYNIC-iPSMA SPECT/CT and 68Ga-PSMA-11 PET/CT a prospective study in biochemical …
FO García-Pérez, J Davanzo… - American journal of …, 2018 - ncbi.nlm.nih.gov
Positron emission tomography (PET) with prostate-specific membrane antigen (PSMA) has
found widespread use for the diagnosis of biochemical recurrence of prostate cancer (PCa). …
found widespread use for the diagnosis of biochemical recurrence of prostate cancer (PCa). …
[HTML][HTML] 177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer
…, G Ferro-Flores, FO García-Pérez… - Contrast media & …, 2018 - hindawi.com
SPECT/CT images in patients have demonstrated the ability of [ 99m Tc]Tc-EDDA/HYNIC-Lys(Nal)-Urea-Glu
([ 99m Tc]Tc-iPSMA) to detect tumors and metastases of prostate cancer. …
([ 99m Tc]Tc-iPSMA) to detect tumors and metastases of prostate cancer. …
[HTML][HTML] [99mTc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities
…, G Ferro-Flores, C Santos-Cuevas, FO García-Pérez… - Pharmaceuticals, 2022 - mdpi.com
Fibroblast activation protein (FAP) is highly expressed on the cancer-associated fibroblasts (CAF)
of the tumor stroma. Recently, we reported the preclinical evaluation and clinical …
of the tumor stroma. Recently, we reported the preclinical evaluation and clinical …